Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
This study represents the first administration of GSK625433 in humans. The study is designed to evaluate initial safety and tolerability in healthy adults as well as anti-viral activity in Hepatitis C(HVC) infected adults. The way the human body processes GSK625433 will also be investigated.
Epistemonikos ID: 68f1376e1d7e71fa367a899c9147b1969aedcd0b
First added on: May 04, 2024